Volume 24, Number 4—April 2018
Carbapenem-Nonsusceptible Acinetobacter baumannii, 8 US Metropolitan Areas, 2012–2015
|Healthcare exposure||No. (%)|
|Healthcare facility exposure in the year before sample collection†||528 (88.3)|
|Previous acute care hospitalization||469 (78.4)|
|Residence in long-term care facility||360 (60.2)|
|Inpatient or outpatient surgery||199 (33.3)|
| Admission to long-term acute care hospital‡
|Current hemodialysis treatment
|Any indwelling device in place in 2 calendar days before sample collection||506 (84.6)|
|Urinary catheter||399 (66.7)|
|Central venous catheter||222 (37.1)|
|No healthcare exposure||8 (1.3)|
*The study areas were Denver, CO; Atlanta, GA; Baltimore, MD; Minneapolis/Saint Paul, MN; Albuquerque, NM; Rochester, NY; Portland, OR; Nashville, TN.
†Sum of subcategory percentages >100 due to patients with multiple healthcare exposures in year before case.
‡2013–2015 cases only; n = 521.
§Other indwelling devices: endotracheal or nasotracheal tube, tracheostomy, gastrostomy tube, nephrostomy tube, nasogastric tube.